That is very important, due to the fact that the method a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and be effective. To put it simply, we have to know how these proteins fold if we want a drug to work. Historically, this has actually been a trial-and-error process (self-driving cars). But now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're created to do. This was a development nearly no one discovered. However it's going to have extensive ramifications for curing illness. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be plenty of investment opportunities in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (brownstone research). That said, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it drew back maybe significantly before going greater - jeff brown prediction. I've been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That shows you where the conversation was at the time. We were mainly informing readers. But that's not the big concern any longer. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. Mass, Mutual is a trusted 170-year-old institution. So think about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big reason I'm bullish on it this year. last week. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus prediction 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I forecast 2021 will be another record year in IPOs. There are a lot of excellent private companies on the brink of hitting the public markets And I've been dealing with a brand-new way for you to invest even before these companies go public.
This opportunity has actually been developing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the details. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Journal. Routine Diary readers know that tech isn't our typical beat (united arab emirates). And when it pertains to tech investing, we leave it to the experts. Fortunately, we have several such specialists in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is among the most accomplished tech investing professionals we understand (the legacy report predictions). In fact, he had a number of triple-digit returns in his Brownstone Research study portfolios in 2015. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the huge photo and forecast what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and far more. These trends are experiencing exponential growth and producing amazing opportunities for financiers. I desire to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the image of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown prediction. But regardless of what numerous readers might think, this is a pattern that's just getting going. Although the COVID-19 pandemic disrupted supply chains last year, an excellent 250 million 5G-enabled devices were still sold.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (united arab emirates). Losing 2 months of production and sales truly impacts how many 5G gadgets are sold in the fiscal year. When you consider all of that, selling 250 million units is impressive. More significantly, the hold-ups brought on by the pandemic produced a heap of pent-up demand. Which need is now going to be pushed into 2021. In reality, I forecast that more than 500 million 5G devices will be delivered in 2021 - future report review. Which's not my only 5G forecast When I've discussed 5G in the past, I have actually explained its 3 various stages.
In Phase 2, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Phase Three, 5G services begin to be provided (genetic sequencing companies jeff brown). That's when we begin to see applications running on 5G networks. Think of things like massive multiplayer games over a mobile phone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will begin Phase 3 by this summer. This begins something of a virtuous cycle: The majority of people do not actually care about the innovation. However they will care if there are amazing applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open up a suite of unbelievable applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations need 5G. The financial investment chances moving forward will be enormous. Stepping far from 5G, the next important technology I visualize in 2021 is CRISPR hereditary modifying. CRISPR means "clustered frequently interspaced brief palindromic repeat." It's a mouthful. But it's one of the most interesting advancements in biotechnology. At a high level, CRISPR is an innovation that can modify our hereditary makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a similar idea however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For several years, CRISPR was mostly a niche technology that wasn't well understood. And during that time, there were actually only 3 companies running in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing actual results. We're dealing with illness and seeing that this innovation just works. And as a result, a "second crop" of early-stage CRISPR companies is going public and delivering amazing returns. This whole industry is successfully a greenfield chance.
There's room for many companies to exist in this area. jeff brown genetic sequencing stock. And there will be more. That's my prediction for CRISPR in 2021. I forecast that two or three more hereditary modifying business will hold their IPOs. Sticking with biotechnology, we are seeing fantastic things occurring at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its newest Alpha, Fold software can accurately forecast the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That's crucial because the method a protein in the human body folds determines if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has actually been a trial-and-error process. But now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. And here's my next forecast. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one however several drug treatments produced using this innovation. This was among those breakthroughs that nearly no one observed. However it's going to have profound ramifications for curing disease. And, of course, there will be a lot of financial investment opportunities in this area, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be amazed if it drew back possibly significantly prior to going higher. I've been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin - jeff brown tech stock 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my suggestion. However at the time of that preliminary suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
However nobody is asking that question any longer. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. jeff brown biotech picks. Mass, Mutual is a 150-year-old organization. So think about that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the information is up to date as of February 2021, however we could not independently validate this claim. Provided Jeff Brown's past, he likely has a significant net worth, however we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like capability to select winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's substantial experience provides him an exceptional viewpoint on the marketplace. He's constantly on the hunt for brand-new opportunities, and he shares many of his best picks in the Near Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively predicted some of the greatest financial events of the previous twenty years. Although he does not appear to launch his picks to the public, the service's success is a direct indicator of Brown's stock-picking expertise. No one on Wall Street gets it ideal every time, but Jeff Brown's precise predictions have actually earned him legions of devoted fans. That says a lot about his capability. The Future Report is released by Brownstone Research, a popular monetary research study publisher. Brownstone Research offers numerous research services with a variety of specializations - white house.
The company is likewise connected with Bonner & Partners, another well-respected research study publisher - jeff brown investment prediction. On its website, Brownstone says its objective is to provide retail financiers with professional-grade research study: "For too long, the finest investment research study has not been readily available to private investors. It has actually been usually booked for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown market predictions. The objective of Brownstone Research is to make that type of exclusive research study readily available to any investors aiming to gain an edge in the markets. The goal is easy to deliver distinct and rewarding financial investment research study found nowhere else." -Brownstone Research study site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also functions as the company's Chief Financial investment Analyst.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout many of America. If you know even a bit about the marketplace, you know that he has a reputation as a King Midas of sorts. biotech stocks jeff brown. Whatever he touches relies on gold! Jeff is well aware of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown believes S.A.V. jeff brown biotech genome sequencing. could be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 advanced innovations: synthetic intelligence and electric vehicles. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving cars ever. It's absolutely nothing except the vehicle industry's Holy Grail. As you understand, electric cars and self-driving car stocks have actually been big this year, but the Wall Street maker has actually been big on buzz without much concrete result. Regardless of an extreme increase in competition over the past couple of years, Brown still thinks Musk has the best chance of putting it all together.
tech might be the magic string that ties all of it together. S.A.V. represents Shared Autonomous Automobile, and it could be the future of transport. Generally, this technology would permit you to rent your cars and truck as an autonomous, self-driving taxi when you're not using it. You merely get out of the vehicle and press a button on an app that tells the cars and truck to "sign up with the fleet." Next thing you understand, you're unwinding on your couch while your vehicle shuttles ride-sharers around town. Most importantly, you get to keep a significant chunk of the revenues. It sounds insane, but it could be closed than you think.